Clinical trial
Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation
NCT02428010 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 30, 2014
- Completion date
- April 30, 2021
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.